See more : UnitedHealth Group Inc (UNH.NE) Income Statement Analysis – Financial Results
Complete financial analysis of Zymergen Inc. (ZY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zymergen Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Eastroc Beverage (Group) Co.,Ltd. (605499.SS) Income Statement Analysis – Financial Results
- Nishimatsu Construction Co., Ltd. (1820.T) Income Statement Analysis – Financial Results
- Daiwa Securities Group Inc. (DSECF) Income Statement Analysis – Financial Results
- Sekisui House, Ltd. (SKHSY) Income Statement Analysis – Financial Results
- Himalaya Shipping Ltd (J1X.SG) Income Statement Analysis – Financial Results
Zymergen Inc. (ZY)
About Zymergen Inc.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
| Metric | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue | 16.74M | 13.28M | 15.42M |
| Cost of Revenue | 69.72M | 84.82M | 102.64M |
| Gross Profit | -52.98M | -71.53M | -87.22M |
| Gross Profit Ratio | -316.42% | -538.50% | -565.67% |
| Research & Development | 159.12M | 90.85M | 50.72M |
| General & Administrative | 83.01M | 60.08M | 61.25M |
| Selling & Marketing | 23.65M | 18.63M | 24.14M |
| SG&A | 106.66M | 78.70M | 85.39M |
| Other Expenses | 175.51M | 0.00 | 0.00 |
| Operating Expenses | 265.78M | 169.56M | 136.10M |
| Cost & Expenses | 335.50M | 254.37M | 238.74M |
| Interest Income | 64.00K | 492.00K | 4.92M |
| Interest Expense | 14.71M | 10.96M | 2.94M |
| Depreciation & Amortization | 20.70M | 18.71M | 15.20M |
| EBITDA | -326.33M | -232.58M | -218.65M |
| EBITDA Ratio | -1,949.08% | -1,750.80% | -1,418.08% |
| Operating Income | -347.03M | -241.09M | -237.11M |
| Operating Income Ratio | -2,072.68% | -1,814.88% | -1,537.80% |
| Total Other Income/Expenses | -14.71M | -21.15M | 318.00K |
| Income Before Tax | -361.73M | -262.24M | -236.80M |
| Income Before Tax Ratio | -2,160.51% | -1,974.13% | -1,535.74% |
| Income Tax Expense | 51.00K | -49.00K | 8.00K |
| Net Income | -361.79M | -262.19M | -236.80M |
| Net Income Ratio | -2,160.81% | -1,973.76% | -1,535.79% |
| EPS | -4.87 | -2.68 | -2.42 |
| EPS Diluted | -4.87 | -2.68 | -2.42 |
| Weighted Avg Shares Out | 74.31M | 97.94M | 97.94M |
| Weighted Avg Shares Out (Dil) | 74.31M | 97.94M | 97.94M |
Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business Update
EMERYVILLE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), a leading biofacturing company, today reported preliminary financial results for the third quarter ended September 30, 2021.
Why Zymergen Stock Sank Today
Insiders seem to be selling their shares in Zymergen on uncertainty about the once-hot stock's future.
The Inside Story Of How SoftBank-Backed Zymergen Imploded Four Months After Its $3 Billion IPO
Zymergen raised $500 million when it went public in April, on top of more than $1 billion in venture funding. By August, its CEO was out and the synthetic biology company wouldn't say when it might have commercial revenue.
ZY ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2021 in the Class Action Filed on Behalf of Zymergen Inc. Limited Shareholders
New York, New York--(Newsfile Corp. - October 4, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zymergen Inc. (NASDAQ: ZY) alleging that the Company violated federal securities laws.This...
Last Few Hours for Shareholders to Actively Participate in Zymergen, Inc. (ZY) Class Action: Bronstein, Gewirtz & Grossman, LLC
New York, New York--(Newsfile Corp. - October 4, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zymergen, Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) and certain of its officers, on...
Last Few Hours for Shareholders to Actively Participate in Zymergen, Inc. (ZY) Class Action: Bronstein, Gewirtz & Grossman, LLC
New York, New York--(Newsfile Corp. - October 4, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zymergen, Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) and certain of its officers, on...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zymergen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - ZY
New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Zymergen Inc. (NASDAQ: ZY) ("Zymergen") This lawsuit is on behalf...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zymergen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - ZY
New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Zymergen Inc. (NASDAQ: ZY) ("Zymergen") This lawsuit is on behalf...
ZY Final Deadline Tomorrow: Rosen, A Top Ranked Law Firm, Encourages Zymergen Inc. Investors with Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - ZY
New York, New York--(Newsfile Corp. - October 3, 2021) - WHY: New York, N.Y., October 3, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to...
ZY Final Deadline Tomorrow: Rosen, A Top Ranked Law Firm, Encourages Zymergen Inc. Investors with Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - ZY
New York, New York--(Newsfile Corp. - October 3, 2021) - WHY: New York, N.Y., October 3, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to...
Source: https://incomestatements.info
Category: Stock Reports